BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Pro-Dex, Inc. Announces Fiscal 2023 Second Quarter and Six-Month Results

  PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2023 second quarter ended December 31, 2022.

  February 2, 2023

   · 

  6 min read
• Business

  Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call

  Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Tuesday, February 21, 2023.

  February 2, 2023

   · 

  3 min read
• Freeline Reports January 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  Freeline Therapeutics Holdings plc announced that on January 31, 2023, the Company granted two newly hired employees non-statutory options to purchase an aggregate of 81,000 of the Company’s ordinary shares.

  February 2, 2023

   · 

  1 min read
• Business

  Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership

  Amarin Corporation plc announced that it has mailed a letter to shareholders in connection with the General Meeting of Shareholders urging shareholders to vote “AGAINST” all proposals on the WHITE proxy card.

  February 2, 2023

   · 

  10 min read
• Biotech Bay

  Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 02, 2023

  Olema Pharmaceuticals, Inc. announced that the Company granted stock options to four new employees to purchase an aggregate of 97,200 shares of the Company’s common stock, effective as of February 1, 2023.

  February 2, 2023

   · 

  2 min read
• Deals

  Tonix Pharmaceuticals Announces Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio, Inc.

  Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an agreement whereby Tonix has acquired all of the assets of Healion Bio, Inc. (Healion) including its entire portfolio of next-generation antiviral technology assets.

  February 2, 2023

   · 

  7 min read
• Mindset Pharma Receives Another Allowance from USPTO for Patent Application Expanding Composition of Matter for Family 1 Psilocybin Analogs

  Mindset Pharma Inc. announced today that the United States Patent and Trademark Office (“USPTO”) has granted allowance for another of Mindset’s Family 1 patent applications, number 17/743,718, titled “Psilocin Derivatives As Serotonergic Psychedelic Agents for the Treatment of CNS Disorders.”

  February 2, 2023

   · 

  3 min read
• Business

  ProSciento Appoints David Sockolof as Chief Financial Officer

  ProSciento, Inc., a leading specialty clinical research organization (CRO) exclusively focused on metabolic diseases, today announced the appointment of David Sockolof to the role of Chief Financial Officer (CFO).

  February 2, 2023

   · 

  2 min read
• BioForest

  CTI BioPharma to Participate in Upcoming Investor Conferences in February 2023

  CTI BioPharma Corp. (Nasdaq: CTIC) today announced that senior leadership will participate in a Fireside Chat at the following investor conferences in February 2023.

  February 2, 2023

   · 

  1 min read
• JMIR AI | A NEW ADDITION TO THE JMIR PUBLICATIONS JOURNAL PORTFOLIO

  JMIR AI is focused on the intersection between clinical neuroscience and technology to prevent, diagnose, and treat neurological disorders.

  February 2, 2023

   · 

  5 min read